Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 391.50
-17.50 (-4.28%)
Nov 10, 2026, 1:30 PM CST
Bora Pharmaceuticals Market Cap
Bora Pharmaceuticals has a market cap or net worth of 49.83 billion as of November 9, 2026. It is the 7,778th most valuable company in the world and the 208th biggest in Taiwan. Its market cap has decreased by 35.45% in one year.
Market Cap
49.83B
Enterprise Value
65.57B
Revenue
19.56B
Global Rank
Country Rank
#208 Taiwan
PE Ratio
49.93
ChartMarket Cap Chart
Since October 3, 2014, Bora Pharmaceuticals's market cap has increased from 3.16B to 49.83B, an increase of 1,476.06%. That is a compound annual growth rate of 25.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 49.83B | -17.66% |
| Dec 31, 2025 | 60.52B | -22.12% |
| Dec 31, 2024 | 77.71B | 20.27% |
| Dec 29, 2023 | 64.61B | 107.61% |
| Dec 30, 2022 | 31.12B | 150.04% |
| Dec 30, 2021 | 12.45B | 17.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lotus Pharmaceutical | 44.77B |
| Center Laboratories | 22.31B |
| TTY Biopharm Company | 19.69B |
| Handa Pharmaceuticals | 16.98B |
| ScinoPharm Taiwan | 15.93B |
| YungShin Global Holding | 15.66B |
| Synmosa Biopharma | 14.72B |
| Grape King Bio | 11.93B |